MeSH D009293 - opioid-related disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000079524:Narcotic-related disorders
0 Companies
0 Drugs
Success rate
D009293:
Opioid-related disorders
D000074607:Opium dependence
0 Companies
0 Drugs
Success rate
D000083682:Opiate overdose
0 Companies
0 Drugs
Success rate
D006556:Heroin dependence
D009021:Morphine dependence
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Buprenorphine, Naloxone | Buprenorphine Naloxone | 2014-09-08 | |||
| Buprenorphine, Naloxone | Cassipa | 2018-09-07 | ||||
| Naloxone | Naloxone | 2019-04-19 | ||||
| Naltrexone | Revia | 1984-11-20 | ||||
| Naltrexone | Naltrexone | 2023-07-06 | ||||
| Padagis | Naloxone | Naloxone | 2022-06-21 | |||
| Mylan | Buprenorphine, Naloxone | Buprenorphine Naloxone | 2018-06-14 | |||
| Methadone | Methadone | 1982-01-01 | ||||
| Naloxone | Naloxone | 2014-03-06 | ||||
| Lupin Research | Pentazocine, Naloxone | Naloxone Pentazocine | 2001-07-11 | |||
| Sandoz | Methadone | Westadone | 1982-01-01 | |||
| AstraZeneca | Naloxone | Naloxone | 1989-04-11 | |||
| Sanofi | Pentazocine, Naloxone | Talwin | 1982-12-16 | |||
| Wyeth | Naloxone | Naloxone | 1986-09-24 | |||
| Bausch Health Companies | Methylnaltrexone | Relistor | 2008-07-01 | |||
| Dr Reddys Laboratories | Buprenorphine, Naloxone | Buprenorphine Naloxone | 2018-06-14 | |||
| Naloxone | Naloxone | 2020-03-16 |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
69%33/48
Phase 2
45%30/66
Phase 3
60%24/40
Approved: 10Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use